Bowel Cancer Survival Rate – Guide by Stage Age and Treatment

Bowel cancer survival depends heavily on the stage at diagnosis, the patient’s age, and whether treatment is given. In the UK, five-year survival ranges from around 90% for stage 1 disease to approximately 10% for stage 4. Younger patients tend to have better outcomes, and survival without treatment is often measured in months rather than years.

Understanding these numbers is not straightforward. Survival statistics are based on large groups of people and cannot predict an individual’s future. Factors such as overall health, tumour biology, and response to therapy all play a role. The figures below are drawn from the most authoritative UK and international sources available and reflect the most recent data as of 2025.

Bowel cancer remains a major cause of death in the UK, with more than 16,800 deaths each year according to Bowel Cancer UK. However, survival has more than doubled over the last four decades, driven by screening, earlier diagnosis, and better treatments.

Bowel Cancer Survival Rates by Age

Age at diagnosis is one of the strongest predictors of bowel cancer survival. Younger patients generally have better outcomes, but the pattern holds across all stages of disease.

• Early diagnosis dramatically improves survival: from >90% at stage 1 to ~15% at stage 4.
• Survival rates vary significantly by age, with younger patients generally having better outcomes.
• Without any treatment, survival is extremely limited; median survival for elderly without surgery was 1.6 years in one study.
• UK survival rates are comparable to other high-income countries, with 1-year net survival around 78% for all stages combined.
• Advances in screening and treatment have steadily improved bowel cancer survival over the past few decades.

In the UK, data from Dr Jamie Murphy summarises the pattern: survival is highest at 69% for those aged 15–39, and drops to 46% for patients aged 80–89. These figures are not stage-specific but reflect the general trend. Cancer Research UK adds that 53.9% of patients survive bowel cancer for 10 years or more overall, with younger adults faring better.

From the Mayo Clinic (US data), age-and-stage breakdown shows that for localized colorectal cancer, under-50 patients have a 95.0% five-year survival versus 90.5% for those 50 and older. For regional disease, the gap is 79.6% versus 72.3%. For distant disease, it is 22.4% versus 14.0%. These figures are not UK-specific but illustrate the consistent advantage of younger age at every stage.

What Are Bowel Cancer Survival Rates by Stage?

Stage 1 Bowel Cancer

Stage 1 bowel cancer is highly treatable. Cancer Research UK reports a five-year survival rate of around 90% in England for patients diagnosed between 2016 and 2020. Many patients are cured, especially when the cancer is detected through Sexual Health Clinic Near Me – Find Free NHS Walk-Ins & Bookings screening or early symptoms.

Stage 2 Bowel Cancer

At stage 2, the cancer has grown deeper into the bowel wall but has not typically spread to lymph nodes. The UK five-year survival rate is approximately 85%. Treatment usually aims for cure, often involving surgery and sometimes adjuvant chemotherapy depending on risk factors.

Stage 3 Bowel Cancer

Stage 3 means the cancer has spread to nearby lymph nodes. The five-year survival rate in the UK is about 65%. Survival depends on successful surgical removal, the use of chemotherapy, and the patient’s overall fitness. Age continues to play a role: younger patients at stage 3 have better outcomes than older ones.

Stage 4 Bowel Cancer

Stage 4 bowel cancer has spread to distant organs, most commonly the liver or lungs. The UK five-year survival rate is around 10%. Some patients live much longer with modern systemic treatments, but the overall prognosis remains poor. Age also matters here: under-50 patients with distant disease have a 22.4% five-year survival (US data), compared with 14.0% for those 50 and older.

What Is the Bowel Cancer Survival Rate Without Treatment?

There are no standard UK national survival tables for untreated bowel cancer broken down by stage and age. Most survival datasets include patients who receive surgery, chemotherapy, radiotherapy, or palliative care. Information on what happens without treatment is typically inferred from patients who were not suitable for curative surgery, those receiving best supportive care, or older, frailer individuals in observational studies.

Evidence from a study in elderly patients

A study published in the Annals of the Royal College of Surgeons of England examined outcomes in people over 85 with colorectal cancer. It found that those receiving best supportive care had a mean survival of 9.7 months. Patients who underwent curative surgery survived an average of 41.6 months, and those receiving other treatment survived 27.3 months. The study reported that survival was significantly poorer in the best supportive care group, and that after two years, curative surgery showed a clear survival benefit.

In summary, while precise numbers are lacking, the available evidence suggests that without curative treatment, survival can fall to months or a few years, particularly in advanced disease.

Bowel Cancer Survival Rate in the UK

Bowel cancer is the fourth most common cancer in the UK, with about 44,000 new cases each year according to Bowel Cancer UK. Around 94% of new cases occur in people over 50, but more than 2,600 cases are diagnosed in people under 50 annually. The lifetime risk is 1 in 17 for men and 1 in 20 for women.

Survival has improved substantially over the past few decades. The main drivers are screening (the NHS Bowel Cancer Screening Programme), earlier diagnosis, better surgical techniques, and improved chemotherapy and radiotherapy. According to Cancer Research UK, overall five-year survival for all stages combined is around 60-65%, and one-year net survival in England reaches 78.5%.

How Has Bowel Cancer Survival Improved Over the Decades?

1. 1970s: Five-year survival was around 40%. Surgery was the mainstay, and chemotherapy was limited.
2. 1990s: Survival rose to approximately 50%, driven by better surgical techniques and the introduction of adjuvant chemotherapy.
3. 2000s: The NHS Bowel Cancer Screening Programme began (faecal occult blood test), leading to earlier detection. Survival exceeded 60%.
4. 2010s: Targeted therapies (e.g., anti-EGFR drugs) and improved staging became routine. Survival climbed above 60% and continued to rise.
5. 2020s: Immunotherapy for MSI-H bowel cancers and ongoing treatment refinements have pushed five-year survival to around 65% overall.

How Reliable Are Bowel Cancer Survival Statistics?

What Factors Influence Bowel Cancer Survival?

Stage at diagnosis is the single strongest predictor. Screening programmes aim to detect cancer at an early, more treatable stage. In the UK, the NHS FIT test is offered every two years to people aged 60 to 74 (50 to 74 in Scotland). Higher participation rates are linked to better population-level outcomes.

Age affects both the biology of the cancer and the patient’s ability to tolerate aggressive treatment. Younger patients tend to have fewer comorbidities and can often undergo more intensive therapy. The presence of other health conditions (comorbidities) also influences treatment decisions and survival.

Access to specialist care matters. Bowel cancer outcomes in the UK are comparable to other high-income countries, but regional variations exist. The overall improvement in survival since the 1970s reflects better organisation of care, not just new drugs.

What Do Major Health Organizations Say About Bowel Cancer Survival?

“Survival depends on the stage of your bowel (colorectal) cancer when you are diagnosed.”

– Cancer Research UK, Cancer Research UK – Bowel Cancer Survival

“Nearly everyone survives bowel cancer if diagnosed at the earliest stage. However this drops significantly as the disease develops.”

– Bowel Cancer UK, Bowel Cancer UK – What is Bowel Cancer?

“Localized cancer: 91% five-year survival; Regional: 73%; Distant: 13%.”

– Cleveland Clinic, Cleveland Clinic – Colon Cancer Overview

“For all stages combined, 1-year net survival (78.5%) for bowel cancer falls between survival for stages 3 and 4.”

– NHS England, NHS England – Cancer Survival by Stage

“Survival of patients without curative surgery ranged from 105 to 1,782 days with a median life expectancy of 586 days.”

– Annals of the Royal College of Surgeons of England, RCS England – Colon Cancer Survival in Elderly Without Surgery

What Is the Overall Outlook for Bowel Cancer Patients?

The outlook for bowel cancer patients has improved dramatically over the past 50 years. With early diagnosis, most patients can expect to be cured. Even for advanced disease, modern treatments are extending survival beyond what older statistics suggest. Continued improvements in screening, surgery, and systemic therapy mean that the prognosis is better today than at any time in the past. For more information on managing health conditions across the lifespan, you may also find helpful the guide on How Long Does Menopause Last – 7-Year Average, Stages Guide.

Frequently Asked Questions